Shenglin Ma

1.3k total citations
27 papers, 373 citations indexed

About

Shenglin Ma is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shenglin Ma has authored 27 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shenglin Ma's work include Lung Cancer Treatments and Mutations (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Peptidase Inhibition and Analysis (2 papers). Shenglin Ma is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Peptidase Inhibition and Analysis (2 papers). Shenglin Ma collaborates with scholars based in China, United States and Taiwan. Shenglin Ma's co-authors include Yu Hou, Jun Peng, Heyu Ni, Chengshan Guo, Xiaochen Wang, Yunfeng Cheng, Ming Hou, Ruirong Xu, Ting Niu and Yuehua Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Oncology*Biology*Physics and Cell Death and Differentiation.

In The Last Decade

Shenglin Ma

23 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenglin Ma China 12 111 98 79 73 70 27 373
Bahram Chahardouli Iran 12 193 1.7× 145 1.5× 38 0.5× 63 0.9× 39 0.6× 55 430
Chengxin Luo China 10 119 1.1× 61 0.6× 29 0.4× 98 1.3× 35 0.5× 23 363
Leszek Kraj Poland 12 111 1.0× 36 0.4× 66 0.8× 100 1.4× 56 0.8× 32 393
Ming Hou China 14 188 1.7× 216 2.2× 33 0.4× 70 1.0× 39 0.6× 31 461
Mingzhen Yang China 9 144 1.3× 93 0.9× 31 0.4× 37 0.5× 50 0.7× 26 317
Mohamed Mabed Egypt 12 127 1.1× 105 1.1× 27 0.3× 93 1.3× 46 0.7× 41 401
Anneliese Gonzalez United States 10 101 0.9× 22 0.2× 52 0.7× 118 1.6× 65 0.9× 23 348
Li Weng United States 11 312 2.8× 129 1.3× 46 0.6× 120 1.6× 77 1.1× 21 514
Raquel Alves Portugal 13 196 1.8× 179 1.8× 24 0.3× 63 0.9× 63 0.9× 35 421
Kaliopi Chrysovergis United States 7 349 3.1× 74 0.8× 45 0.6× 106 1.5× 129 1.8× 10 503

Countries citing papers authored by Shenglin Ma

Since Specialization
Citations

This map shows the geographic impact of Shenglin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglin Ma more than expected).

Fields of papers citing papers by Shenglin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglin Ma. The network helps show where Shenglin Ma may publish in the future.

Co-authorship network of co-authors of Shenglin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglin Ma. A scholar is included among the top collaborators of Shenglin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglin Ma. Shenglin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Shenglin, et al.. (2025). An analysis of the path of labor protection in the innovation of small and medium-sized enterprises - A moderated mediation model. International Review of Economics & Finance. 99. 104055–104055. 4 indexed citations
2.
Tu, Liangxing, et al.. (2025). A review on polysaccharide-based tumor targeted drug nanodelivery systems. International Journal of Biological Macromolecules. 304(Pt 2). 140820–140820. 8 indexed citations
3.
Hua, Liang, et al.. (2025). An anti-interference attention fusion network-based weld penetration state recognition with multimodal data. Nondestructive Testing And Evaluation. 1–24.
4.
Ma, Shenglin, et al.. (2024). The role of PRMT1 in cellular regulation and disease: Insights into biochemical functions and emerging inhibitors for cancer therapy. European Journal of Pharmaceutical Sciences. 204. 106958–106958. 1 indexed citations
5.
Ren, Shengxiang, Jifeng Feng, Shenglin Ma, et al.. (2023). KEYNOTE‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive, advanced NSCLC. International Journal of Cancer. 153(3). 623–634. 12 indexed citations
6.
Zhao, Yanyan, Shen Gu, Lingjie Li, et al.. (2023). A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma. Neuro-Oncology. 25(12). 2207–2220. 11 indexed citations
7.
Feng, Xing, Xiaoling Xiong, & Shenglin Ma. (2022). Docetaxel-Loaded Novel Nano-Platform for Synergistic Therapy of Non-Small Cell Lung Cancer. Frontiers in Pharmacology. 13. 832725–832725. 11 indexed citations
8.
9.
Zhang, Shirong, Yang Xu, Pan Zhao, et al.. (2021). Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary Component. Frontiers in Oncology. 11. 652193–652193. 15 indexed citations
10.
Zhang, Lidan, et al.. (2020). The impact of respiratory motion and CT pitch on the robustness of radiomics feature extraction in 4DCT lung imaging. Computer Methods and Programs in Biomedicine. 197. 105719–105719. 11 indexed citations
11.
Deng, Qibo, et al.. (2020). Analysis Of Key Factors For Radiomic Feature Extraction Stability And Robustness On 4DCT Image. International Journal of Radiation Oncology*Biology*Physics. 108(3). e783–e783.
12.
13.
14.
Li, Yuan, Kai Zhang, Mengmeng Zhou, et al.. (2019). Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway. Journal of Cancer. 10(25). 6439–6456. 14 indexed citations
15.
Zhao, Ruping, Feng Yan, Jian Wang, et al.. (2018). The influence of anatomic location on outcomes in patients with localized primary soft tissue sarcoma. Japanese Journal of Clinical Oncology. 48(9). 799–805. 5 indexed citations
16.
Xu, Yasi, Dan Su, Lucheng Zhu, et al.. (2018). S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1. Journal of Ovarian Research. 11(1). 39–39. 23 indexed citations
17.
Chen, Sumei, Yuanyuan Chen, Shenglin Ma, et al.. (2016). Dietary fibre intake and risk of breast cancer: A systematic review and meta-analysis of epidemiological studies. Oncotarget. 7(49). 80980–80989. 64 indexed citations
18.
Peng, Jun, Shenglin Ma, Yu Hou, et al.. (2014). Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. Journal of Thrombosis and Haemostasis. 12(4). 497–504. 91 indexed citations
19.
Zhang, Ting, et al.. (2007). [Clinical observation on treatment of radiation pneumonia by Qingjin Runfei Decoction combined with hormone and antibiotic].. PubMed. 27(3). 254–6. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bahram Chahardouli Breakdown of academic impact, for papers by Chengxin Luo Breakdown of academic impact, for papers by Leszek Kraj Breakdown of academic impact, for papers by Ming Hou Breakdown of academic impact, for papers by Mingzhen Yang Breakdown of academic impact, for papers by Mohamed Mabed Breakdown of academic impact, for papers by Anneliese Gonzalez Breakdown of academic impact, for papers by Li Weng Breakdown of academic impact, for papers by Raquel Alves Breakdown of academic impact, for papers by Kaliopi Chrysovergis
Rankless by CCL
2026